Clinical Trial Update: Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating miglitol’s effect on daily plasma glucose in insulin-treated type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MIGLITOL (miglitol)

Snippet

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED